Study Looks at Links Between Cognition, Psychopathology, Weight in Preteens
By Elana Gotkine HealthDay Reporter
WEDNESDAY, June 5, 2024 -- Lower cognition and greater psychopathology at baseline are associated with increased weight gain for children entering adolescence, according to a research letter published online June 3 in JAMA Pediatrics.
Zhaolong Adrian Li, from the Washington University School of Medicine in St. Louis, and colleagues examined how weight indices for children aged 9 to 11 years are associated with changes in cognition and psychopathology across the two years thereafter. The cohort study included baseline and one- and two-year follow-up Adolescent Brain Cognitive Development Study data. Weight indices and psychopathology were assessed annually, and cognition was evaluated at baseline and two years. Data were included for 5,269 participants.
The researchers found no association for baseline body mass index (BMI) with longitudinal changes in cognition. Conversely, lower baseline cognition was associated with greater longitudinal BMI gain overall. There was an association for higher baseline BMI with more longitudinal withdrawn or depression symptoms and depression problems. Compared with those with normal weight, children with overweight or obesity at baseline gained 0.07 and 0.06 more problems annually (172 and 93 percent, respectively). Conversely, there was a broad association seen for greater baseline psychopathology with greater BMI gain (e.g., each baseline endorsement of externalizing problems corresponded to 0.015 more annual BMI increases; 2.2 percent).
"These longitudinal findings highlight the importance of cognitive and mental health to children's healthy weight development and suggest that clinicians should monitor children with overweight or obesity for increased depression problems," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2024
Read this next
Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists
WEDNESDAY, April 30, 2025 -- Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2...
Mental Health, Neurodevelopmental Diagnoses in Publicly Insured Children on the Rise
WEDNESDAY, April 30, 2025 -- The percentage of publicly insured children receiving any mental health or neurodevelopmental disorder diagnosis significantly increased between 2010...
Intensive BP Reduction Effective for Lowering All-Cause Dementia Risk
TUESDAY, April 29, 2025 -- An intensive blood pressure (BP) reduction intervention is effective for lowering the risk for all-cause dementia among individuals aged 40 years and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.